1. Home
  2. Publications
  1. Home
  2. Publications

Filters

Research Groups

Core Facilities

Start date
End date

Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.
Authors: OS Walker, SJ Elsässer, M Mahesh, M Bachman, S Balasubramanian, JW Chin
Research group: Balasubramanian Group
E-pub date: 27 Jan 2016
Journal name: J Am Chem Soc

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.
Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D-E H...
Research group:
E-pub date: 22 Jan 2016
Journal name: Angew Chem Int Ed Engl

Back Cover: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. Int. Ed. 4/2016)
Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D Hu,...
Research group:
E-pub date: 22 Jan 2016
Journal name: Angewandte Chemie International Edition

Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging.
Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D-E H...
Research group:
E-pub date: 22 Jan 2016
Journal name: Angew Chem Weinheim Bergstr Ger

Rücktitelbild: Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging (Angew. Chem. 4/2016)
Authors: AA Neves, YA Wainman, A Wright, MI Kettunen, TB Rodrigues, S McGuire, D Hu,...
Research group:
E-pub date: 22 Jan 2016
Journal name: Angewandte Chemie

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Authors: S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, M Janiszewska, ...
Research group: Carroll Group
E-pub date: 21 Jan 2016
Journal name: Nature

Abstract A11: NGS-based tumor genomic profiling to identify ovarian cancer patients who benefit from the PARP inhibitor rucaparib.
Authors: IA McNeish, KK Lin, JX Sun, S Goble, A Oza, RL Coleman, CL Scott, G Konecny...
Research group: Brenton Group
E-pub date: 15 Jan 2016
Journal name: Clinical Cancer Research

SRC3 Phosphorylation at Serine 543 Is a Positive Independent Prognostic Factor in ER-Positive Breast Cancer.
Authors: W Zwart, KD Flach, B Rudraraju, TMA Abdel-Fatah, O Gojis, S Canisius, D Moo...
Research group: Carroll Group
E-pub date: 15 Jan 2016
Journal name: Clin Cancer Res